244 related articles for article (PubMed ID: 22874897)
1. Canadian population risk of radon induced lung cancer: a re-assessment based on the recent cross-Canada radon survey.
Chen J; Moir D; Whyte J
Radiat Prot Dosimetry; 2012 Nov; 152(1-3):9-13. PubMed ID: 22874897
[TBL] [Abstract][Full Text] [Related]
2. COMPARATIVE STUDY OF RADON EXPOSURE IN CANADIAN HOMES AND URANIUM MINES-A DISCUSSION ON THE IMPORTANCE OF NATIONAL RADON PROGRAM.
Chen J
Radiat Prot Dosimetry; 2017 Nov; 177(1-2):83-86. PubMed ID: 28981856
[TBL] [Abstract][Full Text] [Related]
3. Residential radon in Canada: an uncertainty analysis of population and individual lung cancer risk.
Brand KP; Zielinski JM; Krewski D
Risk Anal; 2005 Apr; 25(2):253-69. PubMed ID: 15876202
[TBL] [Abstract][Full Text] [Related]
4. Assessment and management of residential radon health risks: a report from the health Canada radon workshop.
Tracy BL; Krewski D; Chen J; Zielinski JM; Brand KP; Meyerhof D
J Toxicol Environ Health A; 2006 Apr; 69(7):735-58. PubMed ID: 16608836
[TBL] [Abstract][Full Text] [Related]
5. An update on thoron exposure in Canada with simultaneous ²²²Rn and ²²⁰Rn measurements in Fredericton and Halifax.
Chen J; Moir D; Pronk T; Goodwin T; Janik M; Tokonami S
Radiat Prot Dosimetry; 2011 Nov; 147(4):541-7. PubMed ID: 21216734
[TBL] [Abstract][Full Text] [Related]
6. Estimates of the current and future burden of lung cancer attributable to residential radon exposure in Canada.
Gogna P; Narain TA; O'Sullivan DE; Villeneuve PJ; Demers PA; Hystad P; Brenner DR; Friedenreich CM; King WD;
Prev Med; 2019 May; 122():100-108. PubMed ID: 31078163
[TBL] [Abstract][Full Text] [Related]
7. A combined analysis of North American case-control studies of residential radon and lung cancer.
Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Field RW; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
J Toxicol Environ Health A; 2006 Apr; 69(7):533-97. PubMed ID: 16608828
[TBL] [Abstract][Full Text] [Related]
8. RISK ASSESSMENT FOR RADON EXPOSURE IN VARIOUS INDOOR ENVIRONMENTS.
Chen J
Radiat Prot Dosimetry; 2019 Dec; 185(2):143-150. PubMed ID: 30624757
[TBL] [Abstract][Full Text] [Related]
9. An overview of the North American residential radon and lung cancer case-control studies.
Field RW; Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
J Toxicol Environ Health A; 2006 Apr; 69(7):599-631. PubMed ID: 16608829
[TBL] [Abstract][Full Text] [Related]
10. The Iowa radon lung cancer study--phase I: Residential radon gas exposure and lung cancer.
Field RW; Steck DJ; Smith BJ; Brus CP; Fisher EF; Neuberger JS; Lynch CF
Sci Total Environ; 2001 May; 272(1-3):67-72. PubMed ID: 11379939
[TBL] [Abstract][Full Text] [Related]
11. Canadian individual risks of radon-induced lung cancer for different exposure profiles.
Chen J
Can J Public Health; 2005; 96(5):360-3. PubMed ID: 16238155
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Study of Radon Levels in Federal Buildings and Residential Homes in Canada.
Whyte J; Falcomer R; Chen J
Health Phys; 2019 Sep; 117(3):242-247. PubMed ID: 30913059
[TBL] [Abstract][Full Text] [Related]
13. Population attributable risk associated with lung cancer induced by residential radon in Canada: Sensitivity to relative risk model and radon probability density function choices: In memory of Professor Jan M. Zielinski.
Al-Arydah M
Sci Total Environ; 2017 Oct; 596-597():331-341. PubMed ID: 28437651
[TBL] [Abstract][Full Text] [Related]
14. Quantitative health impact of indoor radon in France.
Ajrouche R; Roudier C; Cléro E; Ielsch G; Gay D; Guillevic J; Marant Micallef C; Vacquier B; Le Tertre A; Laurier D
Radiat Environ Biophys; 2018 Aug; 57(3):205-214. PubMed ID: 29737422
[TBL] [Abstract][Full Text] [Related]
15. Indoor radon and lung cancer risk in connecticut and utah.
Sandler DP; Weinberg CR; Shore DL; Archer VE; Stone MB; Lyon JL; Rothney-Kozlak L; Shepherd M; Stolwijk JA
J Toxicol Environ Health A; 2006 Apr; 69(7):633-54. PubMed ID: 16608830
[TBL] [Abstract][Full Text] [Related]
16. Utility gains from reductions in the modifiable burden of lung cancer attributable to residential radon in Canada.
Gaskin J; Coyle D; Whyte J; Krewski D
Can J Public Health; 2018 Aug; 109(4):598-609. PubMed ID: 30264193
[TBL] [Abstract][Full Text] [Related]
17. CANADIAN POPULATION RISK OF RADON INDUCED LUNG CANCER-VARIATION RANGE ASSESSMENT BASED ON VARIOUS RADON RISK MODELS.
Chen J
Radiat Prot Dosimetry; 2017 Nov; 177(1-2):63-68. PubMed ID: 28981841
[TBL] [Abstract][Full Text] [Related]
18. Estimating the burden of lung cancer in Canada attributed to occupational radon exposure using a novel exposure assessment method.
Ge CB; Kim J; Labrèche F; Heer E; Song C; Arrandale VH; Pahwa M; Peters CE; Demers PA
Int Arch Occup Environ Health; 2020 Oct; 93(7):871-876. PubMed ID: 32232555
[TBL] [Abstract][Full Text] [Related]
19. Radon-thoron discriminative measurements in Gansu Province, China, and their implication for dose estimates.
Yamada Y; Sun Q; Tokonami S; Akiba S; Zhuo W; Hou C; Zhang S; Ishikawa T; Furukawa M; Fukutsu K; Yonehara H
J Toxicol Environ Health A; 2006 Apr; 69(7):723-34. PubMed ID: 16608835
[TBL] [Abstract][Full Text] [Related]
20. An updated assessment of radon exposure in Canada.
Chen J; Moir D
Radiat Prot Dosimetry; 2010 Jul; 140(2):166-70. PubMed ID: 20172936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
